Department of Oncology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic.
Department of Material Chemistry, Institute of Inorganic Chemistry ASCR, Husinec-Rez, Czech Republic.
PLoS One. 2018 Mar 13;13(3):e0193116. doi: 10.1371/journal.pone.0193116. eCollection 2018.
Nanostructured titanium(IV) oxide was used for the destructive adsorption and photocatalytic degradation of mitoxantrone (MTX), a cytostatic drug from the group of anthracycline antibiotics. During adsorption on a titania dioxide surface, four degradation products of MTX, mitoxantrone dicarboxylic acid, 1,4-dihydroxy-5-((2-((2-hydroxyethyl)amino)ethyl)amino)-8-((2-(methylamino)ethyl)amino)anthracene-9,10-dione, 1,4-dihydroxy-5,8-diiminoanthracene-9,10(5H,8H)-dione and 1,4-dihydroxy-5-imino-8-(methyleneamino)anthracene-9,10(5H,8H)-dione, were identified. In the case of photocatalytic degradation, only one degradation product after 15 min at m/z 472 was identified. This degradation product corresponded to mitoxantrone dicarboxylic acid, and complete mineralization was attained in one hour. Destructive adsorbent manganese(IV) oxide, MnO2, was used only for the destructive adsorption of MTX. Destructive adsorption occurred only for one degradation product, mitoxantrone dicarboxylic acid, against anatase TiO2.
纳米结构的二氧化钛被用于米托蒽醌(MTX)的破坏性吸附和光催化降解,米托蒽醌是一种来自蒽环类抗生素的细胞抑制剂药物。在二氧化钛表面吸附时,MTX 的四个降解产物,米托蒽醌二羧酸、1,4-二羟基-5-((2-((2-羟乙基)氨基)乙基)氨基)-8-((2-(甲基氨基)乙基)氨基)蒽-9,10-二酮、1,4-二羟基-5,8-二亚氨基蒽-9,10(5H,8H)-二酮和 1,4-二羟基-5-亚氨基-8-(亚甲基氨基)蒽-9,10(5H,8H)-二酮被鉴定出来。在光催化降解的情况下,在 m/z 472 处仅在 15 分钟后鉴定出一种降解产物。该降解产物对应于米托蒽醌二羧酸,并且在一小时内实现了完全矿化。破坏性吸附剂二氧化锰(MnO2)仅用于 MTX 的破坏性吸附。破坏性吸附仅针对米托蒽醌二羧酸发生在锐钛矿 TiO2 上。